AT297921B - Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen - Google Patents

Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen

Info

Publication number
AT297921B
AT297921B AT711970A AT711970A AT297921B AT 297921 B AT297921 B AT 297921B AT 711970 A AT711970 A AT 711970A AT 711970 A AT711970 A AT 711970A AT 297921 B AT297921 B AT 297921B
Authority
AT
Austria
Prior art keywords
preparation
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
AT711970A
Other languages
English (en)
Inventor
David Maxwell Brown
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Application granted granted Critical
Publication of AT297921B publication Critical patent/AT297921B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT711970A 1969-08-07 1970-08-05 Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen AT297921B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB39610/69A GB1287433A (en) 1969-08-07 1969-08-07 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AT297921B true AT297921B (de) 1972-04-10

Family

ID=10410502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT711970A AT297921B (de) 1969-08-07 1970-08-05 Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen

Country Status (10)

Country Link
AT (1) AT297921B (de)
BE (1) BE754602A (de)
DE (1) DE2038792A1 (de)
ES (1) ES382438A1 (de)
FR (1) FR2068470B1 (de)
GB (1) GB1287433A (de)
IE (1) IE34386B1 (de)
LU (1) LU61447A1 (de)
NL (1) NL7011044A (de)
ZA (1) ZA704998B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668245A (en) * 1986-10-22 1987-05-26 Bankamerica Corporation Fuel additive for use in alcohol fuels
US11130729B2 (en) 2017-06-13 2021-09-28 Lapko Inc. CCL2 inhibitors

Also Published As

Publication number Publication date
FR2068470A1 (de) 1971-08-27
ES382438A1 (es) 1973-04-16
DE2038792A1 (de) 1971-02-18
NL7011044A (de) 1971-02-09
GB1287433A (en) 1972-08-31
LU61447A1 (de) 1970-10-05
IE34386L (en) 1971-02-07
IE34386B1 (en) 1975-04-30
BE754602A (fr) 1971-02-08
FR2068470B1 (de) 1974-02-22
ZA704998B (en) 1971-04-28

Similar Documents

Publication Publication Date Title
AT298508B (de) Verfahren zur Herstellung von Mercaptoalkylalkoxysilanen
CH539642A (de) Verfahren zur Herstellung von Pyrimidinylpyrazolderivaten
AT302277B (de) Verfahren zur Herstellung von Chinondiiminen
CH526566A (de) Verfahren zur Herstellung von 5-Pyridyl-2-imidazolonen
AT299253B (de) Verfahren zur Herstellung von Cyclosiloxanen
CH508604A (de) Verfahren zur Herstellung von Ureidophenylguanidinen
CH521934A (de) Verfahren zur Herstellung von Buten-2-ol-4-Derivaten
CH500992A (de) Verfahren zur Herstellung von pharmazeutischen Verbindungen
AT304774B (de) Verfahren zur Herstellung von 16β-Methyl-9α-fluor-steroiden
CH525881A (de) Verfahren zur Herstellung von 4-Alkylprolinen
CH505041A (de) Verfahren zur Herstellung von Cycloalkenonen
AT296961B (de) Verfahren zur Herstellung von Alkyldihydroxybenzolen
AT319485B (de) Verfahren zur Herstellung von 19-Norsteroiden
CH511225A (de) Verfahren zur Herstellung von Amidophenylthioharnstoffen
AT304759B (de) Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen
AT297921B (de) Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen
AT308086B (de) Verfahren zur Herstellung von 1-Alkoxyanthrachinonen
CH529108A (de) Verfahren zur Herstellung von y-Cyanbutyraldiminen
CH525204A (de) Verfahren zur Herstellung von Glycidsäureamid
AT296297B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen
CH532069A (de) Verfahren zur Herstellung von 3-Hydroxyisoxazolderivaten
AT299905B (de) Verfahren zur Herstellung von β-Acetoxypivalinaldehyd
AT296298B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen
CH506484A (de) Verfahren zur Herstellung von Additionsprodukten
AT299252B (de) Verfahren zur Herstellung von Organo-H-chlorsilanen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee